Inventor
KATHERINE LOUISA WIDDOWSON
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07HSugars22%
A61KPreparations for medical, dental or toiletry purposes17%
C07DHeterocyclic compounds17%
Y02ATechnologies for adaptation to climate change17%
PatentTitleYear
12,552,824C-mannoside compounds useful for the treatment of urinary tract infections202612,351,597Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimH202512,297,223Compounds202511,697,665C-mannoside compounds useful for the treatment of urinary tract infections202311,229,646Method for treating gonorrhea with (2R)-2-({4-[(3,4-dihydro-2H-pyrano[2,3-C]pyridin-6-ylmethyl)amino]-1-piperidinyl}methyl)-1,2-dihydro-3H,8H-2A,5,8A-triazaacenaphthylene-3,8-dione2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to GLAXOSMITHKLINE IP DEV LTD (5)· patent assignee history
2022–2026Based in US· patent location history
2023–2026Patents assigned to FIMBRION THERAPEUTICS INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GLAXOSMITHKLINE IP DEV LTD | 5 | 2022–2026 |
| FIMBRION THERAPEUTICS INC | 4 | 2023–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2026 |